Alobaida Ibrahim A, Malik Rizwan, Ahmad Sameer
Glaucoma Division, King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia.
Saudi J Ophthalmol. 2020 Nov 22;34(1):1-7. doi: 10.4103/1319-4534.301298. eCollection 2020 Jan-Mar.
This retrospective case-control cross-sectional study compared the outcomes of sulcus placement of glaucoma drainage devices (GDD) versus traditional anterior chamber (AC) to test the hypothesis that sulcus placement results in fewer complications whilst maintaining similar efficacy.
This study included 45 patients in the sulcus group and 60 patients in the anterior chamber (AC) group who had undergone surgery from January 2014 to December 2017. Data were collected on pre-operative demographics, operative details and post-operative intraocular pressure and complications. The IOP, number of medications and complications between the two groups was compared. A value of <5% was considered statistically significant.
The sulcus group had significantly lower overall complications compared to the AC group with a comparable IOP decrease between groups. There were significantly lower rates of hyphaema in the sulcus (3 cases) compared to AC group (17 cases) ( < 0.05). Severe or late complications (implant exposure, corneal decompensation, endophthalmitis, poor vision, choroidal hemorrhage and cornea edema) were significantly lower in the sulcus group [2 eyes; 4.4%] compared to the AC group [13 eyes; 21.7%] ( < 0.05). The sulcus group required fewer medications during the follow-up period.
Sulcus implantation of GDD resulted in less postoperative hyphaema and severe complications compared to AC implantation. Our findings concur with the literature that sulcus implantation is safe and effective for controlling IOP for various types of glaucoma. The long-term effects of endothelial cell loss for sulcus versus AC implantation require further evaluation.
本回顾性病例对照横断面研究比较了青光眼引流装置(GDD)沟内植入与传统前房植入的效果,以检验沟内植入并发症更少且疗效相似的假设。
本研究纳入了2014年1月至2017年12月期间接受手术的45例沟内植入组患者和60例前房(AC)植入组患者。收集了术前人口统计学资料、手术细节以及术后眼压和并发症数据。比较了两组之间的眼压、用药数量和并发症情况。P值<5%被认为具有统计学意义。
与AC植入组相比,沟内植入组总体并发症显著更低,两组眼压降低情况相当。与AC植入组(17例)相比,沟内植入组前房积血发生率显著更低(3例)(P<0.05)。与AC植入组[13眼;21.7%]相比,沟内植入组严重或晚期并发症(植入物暴露、角膜失代偿、眼内炎、视力差、脉络膜出血和角膜水肿)显著更低[2眼;4.4%](P<0.05)。沟内植入组在随访期间所需药物更少。
与AC植入相比,GDD沟内植入术后前房积血和严重并发症更少。我们的研究结果与文献一致,即沟内植入对于控制各类青光眼的眼压安全有效。沟内植入与AC植入对内皮细胞丢失的长期影响需要进一步评估。